Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

NCT05681273 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM

Interventions

DRUG: Chiglitazar
DRUG: Empagliflozin
DRUG: Atorvastatin
DRUG: Valsartan

Sponsor

Chipscreen Biosciences, Ltd.